Sanofi to cut US price of its most-prescribed insulin by 78%

Sanofi capping its insulin to a $35 out-of-pocket costs in the U.S.

3 largest providers of insulin in US now cap prices as public pressure grows

Eli Lilly cuts insulin prices in move to make diabetes medicine more affordable

Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insured

Sanofi to cut US price of its most-prescribed insulin by 78%

Eli Lilly vows insulin prices won't rise; Novo Nordisk, Sanofi hedge

Insulin Costs and Rationing

Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors - GeneOnline News

Sanofi cuts price of Lantus, most prescribed insulin in US

Insulin $35 cap price now in effect, lowering costs for many Americans with diabetes

Sanofi cuts insulin cost to $35, third major drug company to do so

Sanofi cuts price of Lantus by 78%, joining Lilly, Novo Nordisk

Sanofi in Lockstep with US Insulin Price Cuts